ClinicalTrials.gg
Drug

Nemolizumab clinical trials

studies test it
26
open now
7
in phase 3
10
first study started
2013

How each study uses nemolizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the nemolizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Aug 2024 · NEMLUVIO · BLA 761390 (FDA, Drugs@FDA)
European Union
12 Feb 2025 · Nemluvio · EMEA/H/C/006149 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nemolizumab
21
CD14152
14
Nemolizumab 30 mg
3

Brand

NEMLUVIO
1

Studies by the year they started

26 studies that test it; most in 2026 (7)

Studies that test nemolizumab, by start year
YearStudies
20131
20172
20194
20203
20213
20224
20231
20251
20267

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
14
Phase 3
10
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 3

Galderma R&D (20) · Maruho Co., Ltd. (1) · Chugai Pharmaceutical (1) · Mayo Clinic (1) · University of Texas Southwestern Medical Center (1) · University of California, San Francisco (1) · The Skin Center Dermatology Group (1)

Often tested with

Tested in the same studies.

Triamcinolone (1) · Fluorouracil (1) · Calcipotriene (1) · Tapinarof (1) · Crisaborole (1) · Tacrolimus (1) · Adalimumab (1) · Etanercept (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test nemolizumab, phase 3 first.

Studies

Open first, then newest update. How each study uses nemolizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test nemolizumab →

Codes

What other systems call nemolizumab · ClinicalTrials.gg INT000569

  • MeSH (NLM) C000612881nemolizumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) GN465U8B72NEMOLIZUMABConfirmed FDA, NLM
  • NCI Thesaurus C170211NemolizumabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.